CLDX

Latest SEC Filings & News for CLDX

1 most recent filing and news item mentioning CLDX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/CLDX/news?limit=20"

Pull CLDX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Celldex amends 2021 Equity Plan

Celldex Therapeutics filed an amendment to its 2021 Omnibus Equity Incentive Plan, expanding available stock by 3.4 million shares. This adjustment impacts future employee retention and compensation structures.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.